Synthetic Biologics Reports 2017 Year End Operational Highlights and Financial Results
— Company Provides Update on Late-stage Microbiome-focused Product Candidates — — Conference Call Today, February 22, 2018, at 8:30 a.m. (EST) — ROCKVILLE, Md., Feb. 22, 2018 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided a […]
Synthetic Biologics Reports 2017 Year End Operational Highlights and Financial Results Read More »